Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty
about
Risk factors for pulmonary embolism after hip and knee arthroplasty: a population-based study.Apixaban and rivaroxaban safety after hip and knee arthroplasty: a meta-analysis.Markers of thrombin generation during resurfacing and noncemented total hip arthroplasty: a pilot study.Patient-reported history of leg ulceration 12-16 years after total primary knee or hip replacement.Does international normalized ratio level predict pulmonary embolism?Aspirin for elective hip and knee arthroplasty: a multimodal thromboprophylaxis protocol50 years ago in CORR: Postspinal anesthesia osteomyelitis of the lumbar spine P. L. Day MD and J. J. Hinchey MD CORR 1958;11:185-193.Thromboprophylaxis for deep vein thrombosis and pulmonary embolism after total joint arthroplasty in a low incidence populationRisk Factor Analysis for 30-Day Mortality After Primary THA in a Single InstitutionImpact of recent guideline changes on aspirin prescribing after knee arthroplasty.Aspirin: an alternative for pulmonary embolism prophylaxis after arthroplasty?High incidence of complications from enoxaparin treatment after arthroplasty.Symptomatic pulmonary embolus after joint arthroplasty: stratification of risk factors.Aspirin for lower limb arthroplasty thromboprophylaxis: review of international guidelines.Important variations in the content of care pathway documents for total knee arthroplasty may lead to quality and patient safety problems.Fast-track hip and knee arthroplasty: clinical and organizational aspects.Dabigatran etexilate for venous thromboembolism: a safety evaluation.Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty.Prophylactic effect of fondaparinux and enoxaparin for preventing pulmonary embolism after total hip or knee arthroplasty: A retrospective observational study using the Japanese Diagnosis Procedure Combination database.Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty.Clinical venous thromboembolism following joint surgery: effect of extended thromboprophylaxis on its annual frequency and postoperative pattern over 22 years.A study of thromboprophylactic practices of Scottish orthopaedic surgeons in patients undergoing total hip replacements. Should practice change with new guidelines?Reply to Letter to Editor: Potent Anticoagulants are Associated with a Higher All-cause Mortality Rate after Hip and Knee Arthroplasty.Aspirin and the prevention of venous thromboembolism following total joint arthroplasty: commonly asked questions.Comparing a Propofol Infusion With General Endotracheal Anesthesia in Plastic Surgery Patients.Ten-Year Trends in Medical Complications Following 540,623 Primary Total Hip Replacements from a National Database.Total Hip Replacement due to Primary Osteoarthritis in Relation to Cumulative Occupational Exposures and Lifestyle Factors: A Nationwide Nested Case-Control Study
P2860
Q33970885-AA750633-AA86-481E-9731-368EA72FEDAEQ34088870-8C556F12-B359-483A-91A5-EBE389453298Q34477080-EDC04F43-337B-49BF-870A-D9DE659A65F3Q35610538-2BB943E9-4731-43A7-8CFB-F976F9AC3056Q35663284-AE4AF255-D9EF-4808-B535-227821F6529EQ36285040-917B98BB-D7F2-4509-BA1F-54646A68CF04Q36826277-F37AA8A4-CBE0-4437-9C8C-22816E894127Q36898082-1CFC9C62-4B48-47CA-A27F-BCC1118B42FCQ37025246-06834083-CAC1-45F9-9038-BA6AE47D97B2Q37353756-2163CB98-3C80-456E-A3BB-E87A32F014FCQ37472397-1A9D1E92-F0B2-416D-AB93-CD69788E5DB7Q37483311-9D239E9C-95A4-4395-AA7F-12FCE9E5DFA7Q37563834-D543B504-52D8-45F0-8144-168A55BD192DQ37834393-00EF789B-519D-4F62-9327-0C901790E01EQ37924921-11DD5EDA-95E4-43E1-9E4F-AADE2FA70113Q38064508-1A7F5D73-C5F5-497D-A30E-401FA7159F2BQ38193599-61B5E420-0059-451C-9000-BA973AF0DCBDQ39004019-34CEAED2-9E11-4679-B754-1D14AB80BEE1Q41663167-2C7665F7-54E4-42A9-8027-1977C7F7116DQ43242110-52ECFF40-8325-4489-9162-BFA9581B5A9DQ43446868-C2CFE961-8CD9-4178-B83C-C4B1C2017F52Q43851093-C20FD2E4-F940-408F-B594-AF023EBC7E5DQ45752159-AE96B94B-7E60-47C5-AD96-E39C4A6F550CQ47133431-9CC533DC-1433-458F-9B21-D4991AFF9274Q47313066-3C231B53-4B93-4288-A871-73F236424079Q54261463-FF5B5358-752B-4CEA-84B6-F6FDFC87174BQ58914770-DEC54E86-45F1-48C4-A005-FED57D6886C8
P2860
Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Potent anticoagulants are asso ...... fter hip and knee arthroplasty
@en
Potent anticoagulants are asso ...... ter hip and knee arthroplasty.
@nl
type
label
Potent anticoagulants are asso ...... fter hip and knee arthroplasty
@en
Potent anticoagulants are asso ...... ter hip and knee arthroplasty.
@nl
prefLabel
Potent anticoagulants are asso ...... fter hip and knee arthroplasty
@en
Potent anticoagulants are asso ...... ter hip and knee arthroplasty.
@nl
P2093
P2860
P1476
Potent anticoagulants are asso ...... fter hip and knee arthroplasty
@en
P2093
Alejandro Gonzalez Della Valle
Eduardo A Salvati
Nigel E Sharrock
Stephen Lyman
P2860
P2888
P304
P356
10.1007/S11999-007-0092-4
P407
P577
2008-02-10T00:00:00Z